Benzinga - Tue, 09 Mar 2021 08:00:33 -0400
Benzinga - Tue, 23 Feb 2021 05:58:31 -0400
Benzinga - Mon, 22 Feb 2021 13:34:13 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. It is primarily operating within the critical care and cancer care market segments.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-13
REV
Q1 2021Est.ActualSurprise
EPS-0.150
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CTXRCitius Pharmaceuticals0.55%246.5M

Citius Pharmaceuticals Company Questions & Answers

Q

How do I buy Citius Pharmaceuticals (CTXR) stock?

A

You can purchase shares of Citius Pharmaceuticals (NASDAQ: CTXR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Citius Pharmaceuticals's (CTXR) main competitors?

A

Other companies in Citius Pharmaceuticals’s space includes: Onconova Therapeutics (NASDAQ:ONTX), BioDelivery Sciences Intl (NASDAQ:BDSI) and WAVE Life Sciences (NASDAQ:WVE).

Q

What is the target price for Citius Pharmaceuticals?

A

The latest price target for Citius Pharmaceuticals (NASDAQ: CTXR) was reported by H.C. Wainwright on 2019-02-07. The analyst firm set a price target for 3.00 expecting CTXR to rise to within 12 months (a possible 63.93% upside). 0 analyst firms have reported ratings in the last year.

Q

How much is Citius Pharmaceuticals (CTXR) stock ?

A

The stock price for Citius Pharmaceuticals (NASDAQ: CTXR) is $1.83 last updated Mon Apr 12 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Citius Pharmaceuticals (CTXR) dividend?

A

There are no upcoming dividends for Citius Pharmaceuticals.

Q

When is Citius Pharmaceuticals (NASDAQ:CTXR) reporting earnings?

A
Citius Pharmaceuticals’s Q2 earnings are confirmed from now on May 13, 2021.
Q

When is the upcoming split for CTXR?

A

There is no upcoming split for Citius Pharmaceuticals.